Modified intention to treat reporting in randomised controlled trials: systematic review - PubMed (original) (raw)
Modified intention to treat reporting in randomised controlled trials: systematic review
Iosief Abraha et al. BMJ. 2010.
Abstract
Objectives: To determine the incidence and characteristics of randomised controlled trials that report using the modified intention to treat approach, and how the approach is described.
Design: Systematic review.
Data sources: PubMed, Embase, Cochrane central register of controlled trials, ISI Web of Knowledge, Ovid, HighWire Press, Science-Direct, Ingenta, Medscape, BioMed Central, Springer, and Wiley, from inception to December 2006.
Main outcome measures: Incidence of trials in which use of modified intention to treat was reported, and how the approach was described (classified according to the type and number of deviations from the intention to treat approach).
Results: 475 randomised controlled trials reported use of a modified intention to treat analysis. Of these, 76 (16%) were published in five highly cited general medical journals. The incidence of all trials that reported use of modified intention to treat published in journals indexed in Medline increased from 0.006% in 1982-6 to 0.5% in 2002-6 (P<0.001 for linear trend). When the description of the modified intention to treat was examined in each trial, 192 (40%) reported one type of deviation from the intention to treat approach, 261 (55%) reported two or more types, and 22 (5%) did not describe any type. In 266 (56%) of the trials the deviation was related to the treatment received, in 196 (41%) to a post baseline assessment, in 118 (25%) to a baseline assessment, in 108 (23%) to a target condition, and in 23 (5%) to follow-up. Post-randomisation exclusions occurred in 380 (80%) trials. The results reported by 270 of the 352 (77%) superiority trials favoured the drug under investigation. All of the 123 trials using equivalence or non-inferiority methods to investigate interventions reported results that favoured their assumptions.
Conclusions: Randomised controlled trials that report using a modified intention to treat are increasingly being published in the medical literature. The descriptions of such an approach were ambiguous, and may cover any type of descriptions for exclusion, such as missing data and deviation from protocol. Explicit statements about post-randomisation exclusions should replace the ambiguous terminology of modified intention to treat.
Conflict of interest statement
Competing interests: All authors have completed the Unified Competing Interest form at www.icmje.org/coi\_disclosure.pdf (available on request from the corresponding author) and declare that (1) none of the authors have support from any company for the submitted work; (2) none of the authors have relationships with any companies that might have an interest in the submitted work in the previous 3 years; (3) none of their spouses, partners, or children have financial relationships that may be relevant to the submitted work; and (4) none of the authors have no non-financial interests that may be relevant to the submitted work.
Figures
Fig 1 Study screening process
Fig 2 Number (percentage) of four most common types of deviations from intention to treat. Each type of deviation overlapped with at least one other type
Similar articles
- Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P. Crider K, et al. Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article. - Deviation from intention to treat analysis in randomised trials and treatment effect estimates: meta-epidemiological study.
Abraha I, Cherubini A, Cozzolino F, De Florio R, Luchetta ML, Rimland JM, Folletti I, Marchesi M, Germani A, Orso M, Eusebi P, Montedori A. Abraha I, et al. BMJ. 2015 May 27;350:h2445. doi: 10.1136/bmj.h2445. BMJ. 2015. PMID: 26016488 Free PMC article. - Modified versus standard intention-to-treat reporting: are there differences in methodological quality, sponsorship, and findings in randomized trials? A cross-sectional study.
Montedori A, Bonacini MI, Casazza G, Luchetta ML, Duca P, Cozzolino F, Abraha I. Montedori A, et al. Trials. 2011 Feb 28;12:58. doi: 10.1186/1745-6215-12-58. Trials. 2011. PMID: 21356072 Free PMC article. - A systematic review found that deviations from intention-to-treat are common in randomized trials and systematic reviews.
Abraha I, Cozzolino F, Orso M, Marchesi M, Germani A, Lombardo G, Eusebi P, De Florio R, Luchetta ML, Iorio A, Montedori A. Abraha I, et al. J Clin Epidemiol. 2017 Apr;84:37-46. doi: 10.1016/j.jclinepi.2016.11.012. Epub 2017 Jan 11. J Clin Epidemiol. 2017. PMID: 28088592 Review. - What is meant by intention to treat analysis? Survey of published randomised controlled trials.
Hollis S, Campbell F. Hollis S, et al. BMJ. 1999 Sep 11;319(7211):670-4. doi: 10.1136/bmj.319.7211.670. BMJ. 1999. PMID: 10480822 Free PMC article. Review.
Cited by
- Current interventional model for movement in Parkinson's disease: network meta-analysis based on the improvement of motor ability.
HongFei Z, Li Z, Liang L, Ru GW, Yi HL, Zhen W. HongFei Z, et al. Front Aging Neurosci. 2024 Sep 10;16:1431277. doi: 10.3389/fnagi.2024.1431277. eCollection 2024. Front Aging Neurosci. 2024. PMID: 39318860 Free PMC article. - Parkinson's disease motor intervention patterns: a network meta-analysis based on patient motor function.
Zhao H, Zhang L, Yang J, Guo W, Sun C, Shi R, Wang Z. Zhao H, et al. Front Neurol. 2024 Sep 5;15:1432256. doi: 10.3389/fneur.2024.1432256. eCollection 2024. Front Neurol. 2024. PMID: 39314864 Free PMC article. - Decompression alone or with fusion for degenerative lumbar spondylolisthesis (Nordsten-DS): five year follow-up of a randomised, multicentre, non-inferiority trial.
Kgomotso EL, Hellum C, Fagerland MW, Solberg T, Brox JI, Storheim K, Hermansen E, Franssen E, Weber C, Brisby H, Algaard KRH, Furunes H, Banitalebi H, Ljøstad I, Indrekvam K, Austevoll IM; Nordsten collaborators. Kgomotso EL, et al. BMJ. 2024 Aug 7;386:e079771. doi: 10.1136/bmj-2024-079771. BMJ. 2024. PMID: 39111800 Free PMC article. Clinical Trial. - Add-On Bifidobacterium Bifidum Supplement in Children with Attention-Deficit/Hyperactivity Disorder: A 12-Week Randomized Double-Blind Placebo-Controlled Clinical Trial.
Wang LJ, Tsai CS, Chou WJ, Kuo HC, Huang YH, Lee SY, Dai HY, Yang CY, Li CJ, Yeh YT. Wang LJ, et al. Nutrients. 2024 Jul 13;16(14):2260. doi: 10.3390/nu16142260. Nutrients. 2024. PMID: 39064703 Free PMC article. Clinical Trial. - Long-lasting improvements in episodic memory among subjects with mild cognitive impairment who received transcranial direct current stimulation combined with cognitive treatment and telerehabilitation: a multicentre, randomized, active-controlled study.
Manenti R, Baglio F, Pagnoni I, Gobbi E, Campana E, Alaimo C, Rossetto F, Di Tella S, Pagliari C, Geviti A, Bonfiglio NS, Calabrò RS, Cimino V, Binetti G, Quartarone A, Bramanti P, Cappa SF, Rossini PM, Cotelli M. Manenti R, et al. Front Aging Neurosci. 2024 Jun 18;16:1414593. doi: 10.3389/fnagi.2024.1414593. eCollection 2024. Front Aging Neurosci. 2024. PMID: 38966802 Free PMC article.
References
- Newell DJ. Intention-to-treat analysis: implications for quantitative and qualitative research. Int J Epidemiol 1992;21:837-41. - PubMed
- Tierney JF, Stewart LA. Investigating patient exclusion bias in meta-analysis. Int J Epidemiol 2005;34:79-87. - PubMed
- Higgins J, Green S. Intention-to-treat issues. In: Cochrane Collaboration. Cochrane handbook for systematic reviews on interventions. Cochrane Collaboration, 2008.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources